These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29162880)

  • 1. FSCN1 gene polymorphisms: biomarkers for the development and progression of breast cancer.
    Wang CQ; Tang CH; Wang Y; Jin L; Wang Q; Li X; Hu GN; Huang BF; Zhao YM; Su CM
    Sci Rep; 2017 Nov; 7(1):15887. PubMed ID: 29162880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Polymorphism in FSCN1 rs3801004 C/G and CD44 rs353639 A/C, as Prognostic Factor in Egyptian Breast Cancer Patients.
    Ibrahim NE; Raafat Hamed RM; Refaat A; Mosaad YO; Mekawy DM
    Asian Pac J Cancer Prev; 2023 Oct; 24(10):3517-3523. PubMed ID: 37898858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The FSCN1 gene rs2966447 variant is associated with increased serum fascin-1 levels and breast cancer susceptibility.
    Abdullah AR; Gamal El-Din AM; Ismail Y; El-Husseiny AA
    Gene; 2024 Nov; 927():148743. PubMed ID: 38964493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of FSCN1 (rs852479, rs1640233) and HOTAIR (rs920778) polymorphisms with the risk of breast cancer in Egyptian women.
    Galal ER; Abdelhakam DA; Ahmed LK; Elhusseny Y; Sayed SEP; Eltaweel NH
    Mol Biol Rep; 2024 Apr; 51(1):495. PubMed ID: 38587571
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Huang BF; Tzeng HE; Chen PC; Wang CQ; Su CM; Wang Y; Hu GN; Zhao YM; Wang Q; Tang CH
    Int J Med Sci; 2018; 15(6):580-586. PubMed ID: 29725248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between LSP1 polymorphisms and the susceptibility to breast cancer.
    Chen H; Qi X; Qiu P; Zhao J
    Int J Clin Exp Pathol; 2015; 8(5):5798-802. PubMed ID: 26191300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
    Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
    BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoskeletal Focal Adhesion Proteins Fascin-1 and Paxillin Are Predictors of Malignant Progression and Poor Prognosis in Human Breast Cancer.
    Omran OM; Al Sheeha M
    J Environ Pathol Toxicol Oncol; 2015; 34(3):201-12. PubMed ID: 26349603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.
    Wang CQ; Li Y; Huang BF; Zhao YM; Yuan H; Guo D; Su CM; Hu GN; Wang Q; Long T; Wang Y; Tang CH; Li X
    Sci Rep; 2017 Nov; 7(1):15654. PubMed ID: 29142206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
    Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
    Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fascin-1 Is a Novel Prognostic Biomarker Associated With Tumor Invasiveness in Adrenocortical Carcinoma.
    Poli G; Ruggiero C; Cantini G; Canu L; Baroni G; Armignacco R; Jouinot A; Santi R; Ercolino T; Ragazzon B; Assie G; Mannelli M; Nesi G; Lalli E; Luconi M
    J Clin Endocrinol Metab; 2019 May; 104(5):1712-1724. PubMed ID: 30476173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer.
    Kaabi B; Belaaloui G; Benbrahim W; Hamizi K; Sadelaoud M; Toumi W; Bounecer H
    Pathol Oncol Res; 2016 Apr; 22(2):357-65. PubMed ID: 26563278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between SIRT1 Gene Polymorphisms and Breast Cancer in Egyptians.
    Rizk SM; Shahin NN; Shaker OG
    PLoS One; 2016; 11(3):e0151901. PubMed ID: 26999517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role and regulatory mechanism of FSCN1 in breast tumorigenesis and progression.
    Chang D; Liu XX; Liu R; Sun JW
    Yi Chuan; 2023 Feb; 45(2):115-127. PubMed ID: 36927659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N‑Myc induces the tumor progression of prostate cancer by regulating FSCN1.
    He G; Li M; Fang L; Xu L; Huang X; Zheng L; Yang L; Luo W; Cai Y; Ma W; Liang C; Yin Y
    Oncol Rep; 2020 Nov; 44(5):2265-2274. PubMed ID: 33000273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic association of deleted in colorectal carcinoma variants with breast cancer risk: A case-control study.
    Liu X; Wang X; Fu SW; Wang M; Kang H; Guan H; Zhang S; Ma X; Lin S; Liu K; Feng Y; Dai C; Dai Z
    Oncotarget; 2016 May; 7(22):32765-73. PubMed ID: 27127179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the c.*229C>T polymorphism of the topoisomerase IIβ binding protein 1 (TopBP1) gene and breast cancer.
    Forma E; Brzeziańska E; Krześlak A; Chwatko G; Jóźwiak P; Szymczyk A; Smolarz B; Romanowicz-Makowska H; Różański W; Bryś M
    Mol Biol Rep; 2013 May; 40(5):3493-502. PubMed ID: 23277395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA PCAT-1 contributes to tumorigenesis by regulating FSCN1 via miR-145-5p in prostate cancer.
    Xu W; Chang J; Du X; Hou J
    Biomed Pharmacother; 2017 Nov; 95():1112-1118. PubMed ID: 28922730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between
    Hu GN; Tzeng HE; Chen PC; Wang CQ; Zhao YM; Wang Y; Su CM; Tang CH
    Int J Med Sci; 2018; 15(11):1179-1186. PubMed ID: 30123055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of promoter methylation of FSCN1 gene and FSCN1 protein expression in differentiated thyroid carcinomas.
    Mahdiannasser M; Haghpanah V; Damavandi E; Kabuli M; Tavangar SM; Larijani B; Ghadami M
    Mol Biol Rep; 2020 Mar; 47(3):2161-2169. PubMed ID: 32072403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.